Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Oaktree Acquisition (OAC) Competitors

OAC vs. TDOC, AUNA, SBC, AIRS, LFMD, TOI, SHLT, CCM, HIMS, and TWST

Should you be buying Oaktree Acquisition stock or one of its competitors? The main competitors of Oaktree Acquisition include Teladoc Health (TDOC), Auna (AUNA), SBC Medical Group (SBC), AirSculpt Technologies (AIRS), LifeMD (LFMD), Oncology Institute (TOI), SHL Telemedicine (SHLT), Concord Medical Services (CCM), Hims & Hers Health (HIMS), and Twist Bioscience (TWST).

Oaktree Acquisition vs.

Oaktree Acquisition (NYSE:OAC) and Teladoc Health (NYSE:TDOC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

In the previous week, Teladoc Health had 14 more articles in the media than Oaktree Acquisition. MarketBeat recorded 14 mentions for Teladoc Health and 0 mentions for Oaktree Acquisition. Teladoc Health's average media sentiment score of 0.21 beat Oaktree Acquisition's score of 0.00 indicating that Teladoc Health is being referred to more favorably in the news media.

Company Overall Sentiment
Oaktree Acquisition Neutral
Teladoc Health Neutral

Oaktree Acquisition has a net margin of 0.00% compared to Teladoc Health's net margin of -37.91%. Oaktree Acquisition's return on equity of 0.00% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree AcquisitionN/A N/A N/A
Teladoc Health -37.91%-10.06%-4.86%

Teladoc Health received 677 more outperform votes than Oaktree Acquisition when rated by MarketBeat users. However, 100.00% of users gave Oaktree Acquisition an outperform vote while only 63.02% of users gave Teladoc Health an outperform vote.

CompanyUnderperformOutperform
Oaktree AcquisitionOutperform Votes
3
100.00%
Underperform Votes
No Votes
Teladoc HealthOutperform Votes
680
63.02%
Underperform Votes
399
36.98%

Oaktree Acquisition has higher earnings, but lower revenue than Teladoc Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree AcquisitionN/AN/A$1.15MN/AN/A
Teladoc Health$2.60B0.68-$220.37M-$5.77-1.79

Teladoc Health has a consensus price target of $12.08, suggesting a potential upside of 17.10%. Given Teladoc Health's stronger consensus rating and higher possible upside, analysts clearly believe Teladoc Health is more favorable than Oaktree Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Teladoc Health
0 Sell rating(s)
14 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.33

47.6% of Oaktree Acquisition shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 1.0% of Teladoc Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Oaktree Acquisition has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500.

Summary

Teladoc Health beats Oaktree Acquisition on 10 of the 15 factors compared between the two stocks.

Get Oaktree Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for OAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OAC vs. The Competition

MetricOaktree AcquisitionOffices & Clinics Of Medical Doctors IndustryMedical SectorNYSE Exchange
Market Cap$801.47M$1.22B$5.61B$20.35B
Dividend YieldN/AN/A5.36%3.62%
P/E RatioN/A15.4089.6942.15
Price / SalesN/A1.901,219.4016.67
Price / Cash377.4538.7544.3420.36
Price / Book159.309.335.135.93
Net Income$1.15M-$52.07M$118.85M$1.01B

Oaktree Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OAC
Oaktree Acquisition
N/A$31.86
+1.0%
N/A+257.6%$801.47MN/A0.00N/AHigh Trading Volume
TDOC
Teladoc Health
2.6538 of 5 stars
$10.21
+1.2%
$12.08
+18.3%
-49.6%$1.76B$2.60B-1.775,600Gap Up
AUNA
Auna
N/A$8.49
+3.2%
$13.40
+57.8%
N/A$627.58M$1.04B0.0014,958Short Interest ↓
SBC
SBC Medical Group
N/A$5.02
+0.4%
N/AN/A$517.16MN/A0.00N/ANews Coverage
AIRS
AirSculpt Technologies
0.409 of 5 stars
$4.75
-7.0%
$5.00
+5.3%
-38.6%$274.94M$188.78M-33.93240Short Interest ↑
LFMD
LifeMD
2.2839 of 5 stars
$5.15
+0.4%
$11.14
+116.4%
-2.6%$223.05M$152.55M-8.05230
TOI
Oncology Institute
2.3576 of 5 stars
$0.78
+3.0%
$2.50
+219.2%
-61.3%$57.46M$378.93M-1.00660Short Interest ↑
News Coverage
SHLT
SHL Telemedicine
1.9936 of 5 stars
$2.80
+2.4%
$11.00
+293.6%
-59.1%$41.85M$57.08M0.00583Gap Up
CCM
Concord Medical Services
0.4382 of 5 stars
$4.26
-10.9%
N/A-34.7%$18.49M$75.69M0.00970Analyst Forecast
Short Interest ↑
HIMS
Hims & Hers Health
3.5279 of 5 stars
$30.56
-1.0%
$25.13
-17.8%
+252.6%$6.68B$872M69.461,046Short Interest ↑
TWST
Twist Bioscience
2.5907 of 5 stars
$52.23
-3.4%
$51.90
-0.6%
+42.4%$3.10B$312.97M-14.51990Upcoming Earnings
Insider Trade
News Coverage

Related Companies and Tools


This page (NYSE:OAC) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners